NCT04377308View on ClinicalTrials.gov

Fluoxetine to Reduce Intubation and Death After COVID19 Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
COVID-19Cytokine Storm
Interventions
DRUG

Fluoxetine

Fluoxetine 20 mg to 60 mg daily given from 2 weeks to 2 months duration

Trial Locations (1)

43614

University of Toledo, Toledo

All Listed Sponsors
lead

University of Toledo Health Science Campus

OTHER

NCT04377308 - Fluoxetine to Reduce Intubation and Death After COVID19 Infection | Biotech Hunter | Biotech Hunter